Mount, M. P., Zhang, Y., Amini, M., Callaghan, S., Kulczycki, J., Mao, Z., . . . Park, D. S. (2013). Perturbation of Transcription Factor Nur77 Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). American Society for Biochemistry and Molecular Biology.
Citación estilo ChicagoMount, Matthew P., Yi Zhang, Mandana Amini, Steve Callaghan, Jerzy Kulczycki, Zixu Mao, Ruth S. Slack, Hymie Anisman, and David S. Park. Perturbation of Transcription Factor Nur77 Expression Mediated By Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). American Society for Biochemistry and Molecular Biology, 2013.
Cita MLAMount, Matthew P., et al. Perturbation of Transcription Factor Nur77 Expression Mediated By Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). American Society for Biochemistry and Molecular Biology, 2013.